A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma
Public ClinicalTrials.gov record NCT02099656. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Placebo-Controlled Bronchoscopy Study to Evaluate the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Patients With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
Study identification
- NCT ID
- NCT02099656
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- Lebrikizumab Drug
- Placebo Drug
- Inhaled corticposteroids (ICS) Drug
- Second Asthma Controller Medication Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 5, 2014
- Primary completion
- Oct 12, 2016
- Completion
- Oct 12, 2016
- Last update posted
- Sep 5, 2017
2014 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85724-5030 | — |
| LAC-USC Medical Center | Los Angeles | California | 90033 | — |
| University of California Davis Health System; Division of Pulmonary and Critical Care Medicine | Sacramento | California | 95817 | — |
| Yale School of Medicine | New Haven | Connecticut | 06510 | — |
| University of Miami School of Medicine - Sylvester at Deerfield | Deerfield Beach | Florida | Suite 200 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Iowa Hospitals & Clinics; Internal Medicine | Iowa City | Iowa | 52242 | — |
| Brigham and Women's Hospital; Pulmonary Division | Boston | Massachusetts | 02115 | — |
| Washington University; Pediatrics | St Louis | Missouri | 63110 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Wake Forest University Baptist Medical Center; Gastroenterology & Digestive Health | Winston-Salem | North Carolina | 27157-1045 | — |
| Pen Memory Center | Philadelphia | Pennsylvania | 19104 | — |
| Temple University Hospital ; Lung Center | Philadelphia | Pennsylvania | 19140 | — |
| University of Pittsburgh Medical Center Health System | Pittsburgh | Pennsylvania | 15213 | — |
| UTMB Pathology Clinical Services | Galveston | Texas | 77555-0743 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02099656, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 5, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02099656 live on ClinicalTrials.gov.